DXCM vs. SOLV: A Head-to-Head Stock Comparison
Here’s a clear look at DXCM and SOLV, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | DXCM | SOLV |
|---|---|---|
| Company Name | DexCom, Inc. | Solventum Corporation |
| Country | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Supplies |
| Market Capitalization | 22.89 billion USD | 12.71 billion USD |
| Currency | USD | USD |
| Exchange | NasdaqGS | NYSE |
| Listing Date | April 14, 2005 | March 26, 2024 |
| Security Type | Common Stock | Common Stock |
DXCM’s market capitalization (22.89 billion USD) is substantially larger than SOLV’s (12.71 billion USD), indicating a significant difference in their market valuations.
Historical Performance
This chart compares the performance of DXCM and SOLV by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | DXCM | SOLV |
|---|---|---|
| 5-Day Price Return | -0.25% | 8.81% |
| 13-Week Price Return | -15.21% | -4.68% |
| 26-Week Price Return | -1.82% | 6.29% |
| 52-Week Price Return | -29.93% | 10.13% |
| Month-to-Date Return | -0.37% | 8.94% |
| Year-to-Date Return | -10.61% | -7.40% |
| 10-Day Avg. Volume | 5.96M | 1.60M |
| 3-Month Avg. Volume | 4.92M | 1.23M |
| 3-Month Volatility | 35.41% | 31.52% |
| Beta | 1.38 | 1.08 |
With betas of 1.38 for DXCM and 1.08 for SOLV, both stocks show similar sensitivity to overall market movements.
Profitability
Return on Equity (TTM)
DXCM
33.83%
Health Care Equipment & Supplies Industry
- Max
- 26.09%
- Q3
- 16.36%
- Median
- 9.89%
- Q1
- 5.94%
- Min
- -5.61%
DXCM’s Return on Equity of 33.83% is exceptionally high, placing it well beyond the typical range for the Health Care Equipment & Supplies industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.
SOLV
36.74%
Health Care Equipment & Supplies Industry
- Max
- 26.09%
- Q3
- 16.36%
- Median
- 9.89%
- Q1
- 5.94%
- Min
- -5.61%
SOLV’s Return on Equity of 36.74% is exceptionally high, placing it well beyond the typical range for the Health Care Equipment & Supplies industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.
Net Profit Margin (TTM)
DXCM
19.31%
Health Care Equipment & Supplies Industry
- Max
- 24.63%
- Q3
- 13.65%
- Median
- 9.10%
- Q1
- 5.79%
- Min
- -3.53%
A Net Profit Margin of 19.31% places DXCM in the upper quartile for the Health Care Equipment & Supplies industry, signifying strong profitability and more effective cost management than most of its peers.
SOLV
18.69%
Health Care Equipment & Supplies Industry
- Max
- 24.63%
- Q3
- 13.65%
- Median
- 9.10%
- Q1
- 5.79%
- Min
- -3.53%
A Net Profit Margin of 18.69% places SOLV in the upper quartile for the Health Care Equipment & Supplies industry, signifying strong profitability and more effective cost management than most of its peers.
Operating Profit Margin (TTM)
DXCM
21.45%
Health Care Equipment & Supplies Industry
- Max
- 29.27%
- Q3
- 19.11%
- Median
- 13.43%
- Q1
- 11.26%
- Min
- 2.10%
An Operating Profit Margin of 21.45% places DXCM in the upper quartile for the Health Care Equipment & Supplies industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
SOLV
25.20%
Health Care Equipment & Supplies Industry
- Max
- 29.27%
- Q3
- 19.11%
- Median
- 13.43%
- Q1
- 11.26%
- Min
- 2.10%
An Operating Profit Margin of 25.20% places SOLV in the upper quartile for the Health Care Equipment & Supplies industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.
Profitability at a Glance
| Symbol | DXCM | SOLV |
|---|---|---|
| Return on Equity (TTM) | 33.83% | 36.74% |
| Return on Assets (TTM) | 13.39% | 10.76% |
| Net Profit Margin (TTM) | 19.31% | 18.69% |
| Operating Profit Margin (TTM) | 21.45% | 25.20% |
| Gross Profit Margin (TTM) | 63.43% | 53.57% |
Financial Strength
Current Ratio (MRQ)
DXCM
1.95
Health Care Equipment & Supplies Industry
- Max
- 5.08
- Q3
- 2.86
- Median
- 2.16
- Q1
- 1.37
- Min
- 0.95
DXCM’s Current Ratio of 1.95 aligns with the median group of the Health Care Equipment & Supplies industry, indicating that its short-term liquidity is in line with its sector peers.
SOLV
1.23
Health Care Equipment & Supplies Industry
- Max
- 5.08
- Q3
- 2.86
- Median
- 2.16
- Q1
- 1.37
- Min
- 0.95
SOLV’s Current Ratio of 1.23 falls into the lower quartile for the Health Care Equipment & Supplies industry. This indicates a tighter liquidity situation and a more constrained capacity to handle short-term debt than many of its competitors.
Debt-to-Equity Ratio (MRQ)
DXCM
0.44
Health Care Equipment & Supplies Industry
- Max
- 1.57
- Q3
- 0.78
- Median
- 0.45
- Q1
- 0.24
- Min
- 0.00
DXCM’s Debt-to-Equity Ratio of 0.44 is typical for the Health Care Equipment & Supplies industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
SOLV
1.00
Health Care Equipment & Supplies Industry
- Max
- 1.57
- Q3
- 0.78
- Median
- 0.45
- Q1
- 0.24
- Min
- 0.00
SOLV’s leverage is in the upper quartile of the Health Care Equipment & Supplies industry, with a Debt-to-Equity Ratio of 1.00. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.
Interest Coverage Ratio (TTM)
DXCM
978.00
Health Care Equipment & Supplies Industry
- Max
- 49.32
- Q3
- 22.52
- Median
- 7.72
- Q1
- 3.82
- Min
- -15.06
With an Interest Coverage Ratio of 978.00, DXCM demonstrates a superior capacity to service its debt, placing it well above the typical range for the Health Care Equipment & Supplies industry. This stems from either robust earnings or a conservative debt load.
SOLV
5.94
Health Care Equipment & Supplies Industry
- Max
- 49.32
- Q3
- 22.52
- Median
- 7.72
- Q1
- 3.82
- Min
- -15.06
SOLV’s Interest Coverage Ratio of 5.94 is positioned comfortably within the norm for the Health Care Equipment & Supplies industry, indicating a standard and healthy capacity to cover its interest payments.
Financial Strength at a Glance
| Symbol | DXCM | SOLV |
|---|---|---|
| Current Ratio (MRQ) | 1.95 | 1.23 |
| Quick Ratio (MRQ) | 1.61 | 0.89 |
| Debt-to-Equity Ratio (MRQ) | 0.44 | 1.00 |
| Interest Coverage Ratio (TTM) | 978.00 | 5.94 |
Growth
Revenue Growth
Revenue Growth at a Glance
| Symbol | DXCM | SOLV |
|---|---|---|
| Revenue Growth (MRQ vs Prior YoY) | 15.05% | -3.71% |
| Revenue Growth (TTM vs Prior YoY) | 16.15% | 0.86% |
| 3-Year Revenue CAGR | 17.01% | 0.79% |
| 5-Year Revenue CAGR | 19.33% | -- |
EPS Growth
EPS Growth at a Glance
| Symbol | DXCM | SOLV |
|---|---|---|
| EPS Growth (MRQ vs Prior YoY) | 95.94% | 108.50% |
| EPS Growth (TTM vs Prior YoY) | 77.45% | 221.66% |
| 3-Year EPS CAGR | 37.23% | 4.46% |
| 5-Year EPS CAGR | 9.54% | -- |
Dividend
Dividend Yield (TTM)
DXCM
0.00%
Health Care Equipment & Supplies Industry
- Max
- 5.83%
- Q3
- 2.51%
- Median
- 1.11%
- Q1
- 0.00%
- Min
- 0.00%
DXCM currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
SOLV
0.00%
Health Care Equipment & Supplies Industry
- Max
- 5.83%
- Q3
- 2.51%
- Median
- 1.11%
- Q1
- 0.00%
- Min
- 0.00%
SOLV currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
Dividend Payout Ratio (TTM)
DXCM
0.00%
Health Care Equipment & Supplies Industry
- Max
- 160.00%
- Q3
- 79.65%
- Median
- 34.80%
- Q1
- 0.00%
- Min
- 0.00%
DXCM has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
SOLV
0.00%
Health Care Equipment & Supplies Industry
- Max
- 160.00%
- Q3
- 79.65%
- Median
- 34.80%
- Q1
- 0.00%
- Min
- 0.00%
SOLV has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
Dividend at a Glance
| Symbol | DXCM | SOLV |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
Price-to-Earnings Ratio (TTM)
DXCM
24.91
Health Care Equipment & Supplies Industry
- Max
- 49.69
- Q3
- 33.04
- Median
- 23.17
- Q1
- 19.91
- Min
- 8.17
DXCM’s P/E Ratio of 24.91 is within the middle range for the Health Care Equipment & Supplies industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
SOLV
8.17
Health Care Equipment & Supplies Industry
- Max
- 49.69
- Q3
- 33.04
- Median
- 23.17
- Q1
- 19.91
- Min
- 8.17
In the lower quartile for the Health Care Equipment & Supplies industry, SOLV’s P/E Ratio of 8.17 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.
Price-to-Sales Ratio (TTM)
DXCM
4.81
Health Care Equipment & Supplies Industry
- Max
- 7.30
- Q3
- 3.92
- Median
- 2.71
- Q1
- 1.65
- Min
- 0.60
DXCM’s P/S Ratio of 4.81 is in the upper echelon for the Health Care Equipment & Supplies industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.
SOLV
1.53
Health Care Equipment & Supplies Industry
- Max
- 7.30
- Q3
- 3.92
- Median
- 2.71
- Q1
- 1.65
- Min
- 0.60
In the lower quartile for the Health Care Equipment & Supplies industry, SOLV’s P/S Ratio of 1.53 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.
Price-to-Book Ratio (MRQ)
DXCM
8.17
Health Care Equipment & Supplies Industry
- Max
- 9.98
- Q3
- 5.44
- Median
- 3.22
- Q1
- 2.19
- Min
- 0.94
DXCM’s P/B Ratio of 8.17 is in the upper tier for the Health Care Equipment & Supplies industry. This indicates that investors are paying a premium relative to the company’s net assets, a valuation that hinges on its ability to generate superior profits.
SOLV
2.72
Health Care Equipment & Supplies Industry
- Max
- 9.98
- Q3
- 5.44
- Median
- 3.22
- Q1
- 2.19
- Min
- 0.94
SOLV’s P/B Ratio of 2.72 is within the conventional range for the Health Care Equipment & Supplies industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | DXCM | SOLV |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 24.91 | 8.17 |
| Price-to-Sales Ratio (TTM) | 4.81 | 1.53 |
| Price-to-Book Ratio (MRQ) | 8.17 | 2.72 |
| Price-to-Free Cash Flow Ratio (TTM) | 16.21 | 135.19 |